Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.

Shackleton B, Crawford F, Bachmeier C.

Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219. [Epub ahead of print]

PMID:
28164773
2.

Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.

Butts AR, Bachmeier CC, Dressler EV, Liu M, Cowden A, Talbert J, Adams VR.

J Oncol Pharm Pract. 2017 Jan 1:1078155216687150. doi: 10.1177/1078155216687150. [Epub ahead of print]

PMID:
28077045
3.

Long title: Translational potential of long-term decreases in mitochondrial lipids in a mouse model of Gulf War Illness.

Abdullah L, Evans JE, Joshi U, Crynen G, Reed J, Mouzon B, Baumann S, Montague H, Zakirova Z, Emmerich T, Bachmeier C, Klimas N, Sullivan K, Mullan M, Ait-Ghezala G, Crawford F.

Toxicology. 2016 Oct 29. pii: S0300-483X(16)30256-6. doi: 10.1016/j.tox.2016.10.012. [Epub ahead of print]

PMID:
27984134
4.

Translational potential of long-term decreases in mitochondrial lipids in a mouse model of Gulf War Illness.

Abdullah L, Evans JE, Joshi U, Crynen G, Reed J, Mouzon B, Baumann S, Montague H, Zakirova Z, Emmerich T, Bachmeier C, Klimas N, Sullivan K, Mullan M, Ait-Ghezala G, Crawford F.

Toxicology. 2016 Nov 30;372:22-33. doi: 10.1016/j.tox.2016.10.012.

PMID:
27931520
5.

Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury.

Lynch CE, Crynen G, Ferguson S, Mouzon B, Paris D, Ojo J, Leary P, Crawford F, Bachmeier C.

Brain Inj. 2016;30(12):1414-1427.

PMID:
27834539
6.

Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.

Shackleton B, Crawford F, Bachmeier C.

Fluids Barriers CNS. 2016 Aug 8;13(1):14. doi: 10.1186/s12987-016-0038-x.

7.

Chronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau Oligomers.

Ojo JO, Mouzon B, Algamal M, Leary P, Lynch C, Abdullah L, Evans J, Mullan M, Bachmeier C, Stewart W, Crawford F.

J Neuropathol Exp Neurol. 2016 Jul;75(7):636-55. doi: 10.1093/jnen/nlw035.

PMID:
27251042
8.

Ultrastructural Changes in the White and Gray Matter of Mice at Chronic Time Points After Repeated Concussive Head Injury.

Ojo JO, Bachmeier C, Mouzon BC, Tzekov R, Mullan M, Davies H, Stewart MG, Crawford F.

J Neuropathol Exp Neurol. 2015 Oct;74(10):1012-35. doi: 10.1097/NEN.0000000000000247.

PMID:
26360375
9.

The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.

Paris D, Ait-Ghezala G, Bachmeier C, Laco G, Beaulieu-Abdelahad D, Lin Y, Jin C, Crawford F, Mullan M.

J Biol Chem. 2014 Dec 5;289(49):33927-44. doi: 10.1074/jbc.M114.608091.

10.

Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.

Bachmeier C, Shackleton B, Ojo J, Paris D, Mullan M, Crawford F.

Neuromolecular Med. 2014 Dec;16(4):686-96.

11.

Neurobehavioral, neuropathological and biochemical profiles in a novel mouse model of co-morbid post-traumatic stress disorder and mild traumatic brain injury.

Ojo JO, Greenberg MB, Leary P, Mouzon B, Bachmeier C, Mullan M, Diamond DM, Crawford F.

Front Behav Neurosci. 2014 Jun 23;8:213. doi: 10.3389/fnbeh.2014.00213.

12.

Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model.

Mouzon BC, Bachmeier C, Ferro A, Ojo JO, Crynen G, Acker CM, Davies P, Mullan M, Stewart W, Crawford F.

Ann Neurol. 2014 Feb;75(2):241-54. doi: 10.1002/ana.24064.

PMID:
24243523
13.

Effect of venlafaxine and desvenlafaxine on drug efflux protein expression and biodistribution in vivo.

Bachmeier C, Levin GM, Beaulieu-Abdelahad D, Reed J, Mullan M.

J Pharm Sci. 2013 Oct;102(10):3838-43. doi: 10.1002/jps.23680.

PMID:
23897419
14.

Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.

Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D.

Mol Cell Neurosci. 2013 Sep;56:255-62. doi: 10.1016/j.mcn.2013.06.004.

PMID:
23831388
15.

Amelioration of experimental autoimmune encephalomyelitis by anatabine.

Paris D, Beaulieu-Abdelahad D, Mullan M, Ait-Ghezala G, Mathura V, Bachmeier C, Crawford F, Mullan MJ.

PLoS One. 2013;8(1):e55392. doi: 10.1371/journal.pone.0055392.

16.

Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice.

Ojo JO, Mouzon B, Greenberg MB, Bachmeier C, Mullan M, Crawford F.

J Neuropathol Exp Neurol. 2013 Feb;72(2):137-51. doi: 10.1097/NEN.0b013e3182814cdf.

PMID:
23334597
17.

Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.

On NH, Mitchell R, Savant SD, Bachmeier CJ, Hatch GM, Miller DW.

J Neurooncol. 2013 Jan;111(2):133-43. doi: 10.1007/s11060-012-1006-1.

18.

Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.

Paris D, Beaulieu-Abdelahad D, Abdullah L, Bachmeier C, Ait-Ghezala G, Reed J, Verma M, Crawford F, Mullan M.

Eur J Pharmacol. 2013 Jan 5;698(1-3):145-53. doi: 10.1016/j.ejphar.2012.11.017.

PMID:
23178521
19.

Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes.

Mouzon B, Chaytow H, Crynen G, Bachmeier C, Stewart J, Mullan M, Stewart W, Crawford F.

J Neurotrauma. 2012 Dec 10;29(18):2761-73. doi: 10.1089/neu.2012.2498.

PMID:
22900595
20.

Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.

Bachmeier C, Beaulieu-Abdelahad D, Crawford F, Mullan M, Paris D.

J Mol Neurosci. 2013 Feb;49(2):270-6. doi: 10.1007/s12031-012-9866-6.

PMID:
22890420
Items per page

Supplemental Content

Loading ...
Support Center